Surrey researchers Sign in
A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with cT1-2 prostate cancer
Conference presentation   Peer reviewed

A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with cT1-2 prostate cancer

P Sooriakumaran, R Laing, P Macanas-Pirard, H Coley, S Fox, G Bucca, D Lovell, A Henderson, C Smith, C Eden, …
JOURNAL OF UROLOGY, Vol.177(4), pp.380-380
102nd Annual Meeting of the American-Urological-Association (Anaheim, CA, 19/05/2007 - 24/05/2007)
01/04/2007

Abstract

Science & Technology Life Sciences & Biomedicine Urology & Nephrology UROLOGY & NEPHROLOGY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245106502170&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

25 Record Views

Details

Usage Policy